The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
暂无分享,去创建一个
C. Craik | A. Unal | D. Ganem | T. Pray | M. Pennington | M. Lagunoff
[1] S. Plafker,et al. Human cytomegalovirus capsid assembly protein precursor (pUL80.5) interacts with itself and with the major capsid protein (pUL86) through two different domains , 1997, Journal of virology.
[2] J. Russo,et al. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Cole. Characterization of human cytomegalovirus protease dimerization by analytical centrifugation. , 1996, Biochemistry.
[4] C. Craik,et al. Intracellular expression of human immunodeficiency virus type 1 (HIV-1) protease variants inhibits replication of wild-type and protease inhibitor-resistant HIV-1 strains in human T-cell lines , 1996, Journal of virology.
[5] I. Kuntz,et al. Engineering human immunodeficiency virus 1 protease heterodimers as macromolecular inhibitors of viral maturation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[6] P. Bonneau,et al. A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease , 1996, Nature.
[7] J. Culp,et al. Unique fold and active site in cytomegalovirus protease , 1996, Nature.
[8] R. Kurumbail,et al. Three-dimensional structure of human cytomegalovirus protease , 1996, Nature.
[9] David A. Matthews,et al. Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic Triad , 1996, Cell.
[10] E. Operskalski,et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.
[11] J. Phair,et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma , 1996, Nature Medicine.
[12] W. Zhong,et al. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Kay,et al. Cloning, expression and characterization of the proteinase from human herpesvirus 6 , 1996, Journal of virology.
[14] L. Kuo,et al. Active Human Cytomegalovirus Protease Is a Dimer (*) , 1996, The Journal of Biological Chemistry.
[15] M. McGrath,et al. Lytic growth of Kaposi's sarcoma–associated herpesvirus (human herpesvirus 8) in culture , 1996, Nature Medicine.
[16] D R Hoover,et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma , 1996, AIDS.
[17] A. Kwong,et al. Identification of a minimal hydrophobic domain in the herpes simplex virus type 1 scaffolding protein which is required for interaction with the major capsid protein , 1996, Journal of virology.
[18] E. Cesarman,et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae , 1996, Journal of virology.
[19] C. Boshoff,et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells , 1995, Nature Medicine.
[20] P. Darke,et al. Activation of the Herpes Simplex Virus Type 1 Protease (*) , 1995, The Journal of Biological Chemistry.
[21] C. Boshoff,et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma , 1995, The Lancet.
[22] F. Sigaux,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. , 1995, Blood.
[23] P. Biberfeld,et al. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma , 1995, Nature Medicine.
[24] W. Gibson,et al. Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad , 1995, Journal of virology.
[25] W. Gibson,et al. Assemblin, a herpes virus serine maturational proteinase and new molecular target for antivirals , 1995 .
[26] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[27] B. Dunn,et al. A continuous fluorescence-based assay of human cytomegalovirus protease using a peptide substrate. , 1995, Analytical biochemistry.
[28] D. Ganem. AIDS: Viruses, cytokines and Kaposi's sarcoma , 1995, Current Biology.
[29] J. Ambroziak,et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. , 1995, Science.
[30] J. Condra,et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors , 1995, Nature.
[31] M. Kaplan,et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.
[32] C. Craik,et al. Structural basis of substrate specificity in the serine proteases , 1995, Protein science : a publication of the Protein Society.
[33] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[34] C. Mapelli,et al. In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease. , 1994, European journal of biochemistry.
[35] K. Duffin,et al. Activity of two-chain recombinant human cytomegalovirus protease. , 1994, The Journal of biological chemistry.
[36] F. Rixon,et al. The herpes simplex virus gene UL26 proteinase in the presence of the UL26.5 gene product promotes the formation of scaffold-like structures. , 1994, The Journal of general virology.
[37] Simon C Watkins,et al. The size and symmetry of B capsids of herpes simplex virus type 1 are determined by the gene products of the UL26 open reading frame , 1994, Journal of virology.
[38] J. Loutsch,et al. Cloning and sequence analysis of murine cytomegalovirus protease and capsid assembly protein genes. , 1994, Biochemical and biophysical research communications.
[39] G. Fields,et al. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). , 1994, The Journal of biological chemistry.
[40] W. Newcomb,et al. The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth , 1994, Journal of virology.
[41] H. Hsiung,et al. Human cytomegalovirus maturational proteinase: expression in Escherichia coli, purification, and enzymatic characterization by using peptide substrate mimics of natural cleavage sites , 1994, Journal of virology.
[42] F. Rixon,et al. Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a. , 1994, The Journal of general virology.
[43] R. Colonno,et al. Identification of the serine residue at the active site of the herpes simplex virus type 1 protease. , 1994, The Journal of biological chemistry.
[44] D. R. Thomsen,et al. Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins , 1994, Journal of virology.
[45] C. Mapelli,et al. In vitro activity of the herpes simplex virus type 1 protease with peptide substrates. , 1993, The Journal of biological chemistry.
[46] W. Gibson,et al. Herpesvirus proteinase: site-directed mutagenesis used to study maturational, release, and inactivation cleavage sites of precursor and to identify a possible catalytic site serine and histidine , 1993, Journal of virology.
[47] L. Babe,et al. Synthetic “interface” peptides alter dimeric assembly of the HIV 1 and 2 proteases , 1992, Protein science : a publication of the Protein Society.
[48] Albrecht,et al. Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.
[49] B. Roizman,et al. Differentiation of multiple domains in the herpes simplex virus 1 protease encoded by the UL26 gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[50] W. Gibson,et al. A herpesvirus maturational proteinase, assemblin: identification of its gene, putative active site domain, and cleavage site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] B. Roizman,et al. The herpes simplex virus 1 gene encoding a protease also contains within its coding domain the gene encoding the more abundant substrate , 1991, Journal of virology.
[52] R. Gallo,et al. Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.
[53] D. King,et al. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. , 1990, International journal of peptide and protein research.
[54] C. Craik,et al. Substrate specificity of trypsin investigated by using a genetic selection. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[55] W. Gibson,et al. Identification of precursor to cytomegalovirus capsid assembly protein and evidence that processing results in loss of its carboxy-terminal end , 1990, Journal of virology.
[56] V. Beral,et al. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? , 1990, The Lancet.
[57] F. Rixon,et al. The products of herpes simplex virus type 1 gene UL26 which are involved in DNA packaging are strongly associated with empty but not with full capsids. , 1988, The Journal of general virology.
[58] S. Bachenheimer,et al. Characterization of intranuclear capsids made by ts morphogenic mutants of HSV-1. , 1988, Virology.
[59] W. Rutter,et al. The catalytic role of the active site aspartic acid in serine proteases. , 1987, Science.
[60] W. Gibson,et al. Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles , 1985, Journal of virology.
[61] F. Rixon,et al. Identification and Characterization of a Herpes Simplex Virus Gene Product Required for Encapsidation of Virus DNA , 1983, Journal of virology.
[62] W. Gibson. Structural and nonstructural proteins of strain Colburn cytomegalovi , 1981 .
[63] B. Roizman,et al. Proteins Specified by Herpes Simplex Virus VIII. Characterization and Composition of Multiple Capsid Forms of Subtypes 1 and 2 , 1972, Journal of virology.
[64] E. Kaiser,et al. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. , 1970, Analytical biochemistry.
[65] P. Spear,et al. Proteins spcified by herpes simplex virus. II. Viral glycoprotins associated with cellular membranes. , 1970, Journal of virology.
[66] A. Berger,et al. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. , 1968, Biochemical and biophysical research communications.
[67] R. Grant,et al. Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. , 1996, The Journal of infectious diseases.
[68] F. Rixon,et al. Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame. , 1992, Virology.
[69] M. Hutt. The epidemiology of Kaposi's sarcoma. , 1981, Antibiotics and chemotherapy.
[70] O'Callaghan Dj,et al. Molecular anatomy of herpesviruses: recent studies. , 1976 .
[71] C. Randall,et al. Molecular anatomy of herpesviruses: recent studies. , 1976, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.